New Therapeutic Tool for Juvenile Idiopathic Arthritis
The aim of this study: to determine which patients need biologic therapy after starting methotrexate.
FDA Safety Alert for Product Marketed for OA
Limbrel capsules linked to potentially life-threatening health problems.
FDA Approves First Drug for Eosinophilic Granulomatosis With Polyangiitis
Mepolizumab gets the nod for the reare disease formerly known as Churg-Strauss syndrome.
Rain Not To Blame for Joint and Back Pain
A commonly held belief has been debunked.
Original Content Source